Are there many people with low-grade squamous lesions?
Low-grade squamous intraepithelial lesion (LSIL) is a relatively common abnormal finding in cervical cytology screening. Among every 100 individuals undergoing cervical cytology testing, approximately five may be diagnosed with LSIL. So, how prevalent is LSIL? Let’s explore this further.

How common is LSIL?
LSIL is indeed common. It represents one of the most frequently encountered abnormal results in cervical cytology screening, with an approximate prevalence of 5%—meaning roughly five out of every 100 individuals undergoing cervical cytology testing will receive an LSIL diagnosis. Individuals diagnosed with LSIL should routinely undergo colposcopy and follow-up evaluation. Colposcopy enables comprehensive assessment of the lower genital tract to monitor disease progression and prevent missed diagnoses. Women who have been sexually active for more than three years or are aged 30 years or older are advised to undergo regular TCT (ThinPrep cytologic test) and HPV testing.

Knowledge Extension: Symptoms of LSIL
LSIL is classified as a precancerous cervical lesion—not yet cancer—and therefore typically causes only mild, reversible symptoms. With prompt and appropriate treatment—and especially in individuals with robust immune function—complete resolution is possible. Specific symptoms may include: 1. Abnormal vaginal discharge—increased volume, yellowish color, foul odor; in severe cases, blood-tinged discharge may be observed. 2. Irregular vaginal bleeding or dyspareunia (painful intercourse) following sexual activity. 3. Persistent dull lower abdominal pain or a sensation of pelvic heaviness or pressure. Initial suspicion of LSIL can often be raised through microscopic examination or imaging studies; however, definitive diagnosis requires histopathological confirmation. Although LSIL has not yet progressed to invasive cancer, without timely intervention, the lesion may evolve over time and potentially undergo malignant transformation. Thus, early detection, accurate diagnosis, and prompt treatment are essential to prevent disease progression.
The above provides an overview of the prevalence of LSIL. We hope this information is helpful to you.